Feb
3
by
CEA Registry Team
2/3/2017 11:40 AM
This week we highlighted findings from recently published cost-effectiveness studies:
- Various colorectal cancer screening strategies compared on relative impact: Among thirteen different screening strategies for colorectal cancer, colonoscopy was determined to be the most cost-effective strategy (1)
- Addition of bedaquiline to treatment regimen of multidrug-resistant tuberculosis found to be effective: Adding bedaquiline to the treatment regimen of multidrug-resistant tuberculosis in select high burden countries led to improvements in health outcomes and reductions in healthcare costs (9)
- Initial plus extended treatment with apixaban for the treatment of venous thromboembolism found to be cost-effective: In the UK, initial plus extended treatment with apixaban for the treatment and prevention of venous thromboembolism was found to be a cost-effective alternative to low-molecular-weight heparin and vitamin K antagonist (8)
See below for a full list of all cost-utility studies and selected reviews and editorials published January 23-27, 2017. To discover more CEA articles or to dive in-depth on some of these topics, please visit the Tufts CEA Registry. Follow us on Twitter (@TuftsCEVR) and Facebook.
1: Barzi A, Lenz HJ, Quinn DI, Sadeghi S. Comparative effectiveness of screening strategies for colorectal cancer. Cancer. 2017 Jan 24. PMID: 28117881.
2: Brar H, Hogen L, Covens A. Cost-effectiveness of sentinel node biopsy and pathological ultrastaging in patients with early-stage cervical cancer. Cancer. 2017 Jan 24. PMID: 28117888.
3: Favato G, Noikokyris E, Vecchiato R. Ecological validity of cost-effectiveness models of universal HPV vaccination: a protocol for a systematic review. Syst Rev. 2017 Jan 25;6(1):17. PMID: 28118846.
4: Goulding JM, Harper N, Kennedy L, Martin KR. Cost-effectiveness in Psychodermatology: A Case Series. Acta Derm Venereol. 2017 Jan 25. PMID: 28120000.
5: Guarda AS, Schreyer CC, Fischer LK, Hansen JL, Coughlin JW, Kaminsky MJ, Attia E, Redgrave GW. Intensive treatment for adults with anorexia nervosa: The cost of weight restoration. Int J Eat Disord. 2017 Jan 27. PMID: 28130794.
6: Hunt B, Vega-Hernandez G, Valentine WJ, Kragh N. Evaluation of the long-term cost-effectiveness of liraglutide versus lixisenatide for treatment of type 2diabetes mellitus in the UK setting. Diabetes Obes Metab. 2017 Jan 26. PMID: 28124820.
7: Kearns B, Rafia R, Leaviss J, Preston L, Brazier JE, Palmer S, Ara R. The cost-effectiveness of changes to the care pathway used to identify depression and provide treatment amongst people with diabetes in England: a model-based economic evaluation. BMC Health Serv Res. 2017 Jan 24;17(1):78. PMID: 28118838.
8: Lanitis T, Leipold R, Hamilton M, Rublee D, Quon P, Browne C, Cohen AT. Cost-effectiveness of apixaban versus low molecular weight heparin/vitamin k antagonist for the treatment of venous thromboembolism and the prevention of recurrences. BMC Health Serv Res. 2017 Jan 23;17(1):74. PMID: 28114939.
9: Lu X, Smare C, Kambili C, El Khoury AC, Wolfson LJ. Health outcomes of bedaquiline in the treatment of multidrug-resistant tuberculosis in selected high burden countries. BMC Health Serv Res. 2017 Jan 26;17(1):87.PMID: 28122562.
10: Sartori AM, Rozman LM, Decimoni TC, Leandro R, Novaes HM, de Soárez PC. A systematic review of health economic evaluations of vaccines in Brazil. Hum Vaccin Immunother. 2017 Jan 27:0. PMID: 28129026.
11: Sawad AB, Seoane-Vazquez E, Rodriguez-Monguio R, Turkistani F. Cost-effectiveness of different strategies for treatment relapsing-remitting multiple sclerosis. J Comp Eff Res. 2017 Jan 25. PMID: 28118731.
12: Schilling C, Petrie D, Dowsey MM, Choong PF, Clarke P. The Impact of Regression to the Mean on Economic Evaluation in Quasi-Experimental Pre-Post Studies: The Example of Total Knee Replacement Using Data from the Osteoarthritis Initiative. Health Econ. 2017 Jan 27. PMID: 28127856.
13: Sharma M, Seoud M, Kim JJ. Cost-effectiveness of increasing cervical cancer screening coverage in the Middle East: An example from Lebanon. Vaccine. 2017 Jan 23;35(4):564-569. PMID: 28017434.
14: Stark Z, Schofield D, Alam K, Wilson W, Mupfeki N, Macciocca I, Shrestha R, White SM, Gaff C. Prospective comparison of the cost-effectiveness of clinical whole-exome sequencing with that of usual care overwhelmingly supports early use and reimbursement. Genet Med. 2017 Jan 26. PMID: 28125081.
15: Wang Y, Yan BP, Liew D, Lee VW. Cost-effectiveness of cytochrome P450 2C19 *2 genotype-guided selection of clopidogrel or ticagrelor in Chinese patients with acute coronary syndrome. Pharmacogenomics J. 2017 Jan 24. PubMed PMID: 28117433.